Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rubrik Inc (Class A) | Ravi Mhatre | Director, Ten Percent Owner | 15 Jan 2025 | 764,208 | 4,330,511 | - | - | Class B Common Stock | ||
| Rubrik Inc (Class A) | Ravi Mhatre | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Jan 2025 | 764,208 | 0 | - | 0 | Class A Common Stock | |
| Rubrik Inc (Class A) | Ravi Mhatre | Director, Ten Percent Owner | 15 Jan 2025 | 764,208 | 764,208 | - | 0 | Class A Common Stock | ||
| BigBear.ai Holdings Inc | Kevin McAleenan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 671,141 | 671,141 | - | - | Stock Option (Right to Buy) | |
| BigBear.ai Holdings Inc | Kevin McAleenan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 628,931 | 794,367 | - | 0 | Common Stock | |
| Rubrik Inc (Class A) | Ravi Mhatre | Director, Ten Percent Owner | 15 Jan 2025 | 534,945 | 3,031,358 | - | - | Class B Common Stock | ||
| Rubrik Inc (Class A) | Ravi Mhatre | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Jan 2025 | 534,945 | 0 | - | 0 | Class A Common Stock | |
| Rubrik Inc (Class A) | Ravi Mhatre | Director, Ten Percent Owner | 15 Jan 2025 | 534,945 | 534,945 | - | 0 | Class A Common Stock | ||
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.48 per share. | 15 Jan 2025 | 500,000 | 213,036,477 (31%) | 0% | 1.5 | 740,850 | Common Stock |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 400,000 | 339,580 | - | - | Stock Option (Right to Buy) | |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.92 per share. | 15 Jan 2025 | 400,000 | 1,216,817 | - | 3.9 | 1,567,360 | Common Stock |
| Spyre Therapeutics Inc | Cameron Turtle | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 370,000 | 370,000 | - | - | Stock Option (Right to Buy) | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 313,126 | 4,070,642 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 313,126 | 746,501 | - | 0 | Class A Common Stock | |
| 374Water Inc | Russell Kline | Chief Financial Officer | 15 Jan 2025 | 308,642 | 348,642 | - | 0 | Common Stock (restricted stock units) | ||
| 374Water Inc | Russell Kline | Chief Financial Officer | 15 Jan 2025 | 308,642 | 308,642 | - | - | Stock options (right to buy) | ||
| Sabra Healthcare REIT Inc | Richard K. Matros | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 285,144 | 812,564 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 15 Jan 2025 | 273,000 | 816,817 | - | 8.4 | 2,304,120 | Common Stock |
| Fate Therapeutics Inc | Jerome Charles Bressi | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Concrete Pumping Holdings Inc (Class A) | Iain Humphries | Director, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 249,287 | 0 | - | - | Option | |
| Concrete Pumping Holdings Inc (Class A) | Iain Humphries | Director, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.09 per share. | 15 Jan 2025 | 249,287 | 636,354 (1%) | 0% | 6.1 | 1,518,158 | Common Stock |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.92 per share. | 15 Jan 2025 | 225,000 | 1,089,817 | - | 3.9 | 881,640 | Common Stock |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 225,000 | 739,580 | - | - | Stock Option (Right to Buy) | |
| Concrete Pumping Holdings Inc (Class A) | Iain Humphries | Director, CFO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.79 per share. | 15 Jan 2025 | 200,920 | 435,434 (0%) | 0% | 8.8 | 1,766,087 | Common Stock |
| Townsquare Media Inc (Class A) | Bill Wilson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 176,110 | 2,623,507 (18%) | 1% | 0 | Class A Common Units | |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 169,950 | 630,201 | - | - | Performance Restricted Stock Units | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 15 Jan 2025 | 166,666 | 166,000 | - | - | Stock Option (Right to Buy) | ||
| Hecla Mining Co. | Robert Krcmarov | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 5.41 per share. | 15 Jan 2025 | 166,359 | 325,016 (0%) | 0% | 5.4 | 900,002 | Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | William Martin E. | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 160,981 | 828,449 | - | 4.6 | 734,073 | Class A Common Stock |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Sale of securities on an exchange or to another person at price $ 8.38 per share. | 15 Jan 2025 | 160,000 | 864,817 | - | 8.4 | 1,340,800 | Common Stock |
| Hecla Mining Co. | Robert Krcmarov | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 5.41 per share. | 15 Jan 2025 | 158,657 | 158,657 (0%) | 0% | 5.4 | 858,334 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Matthew S. Anderson | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 153,781 | 0 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Matthew S. Anderson | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 153,781 | 635,423 | - | 0 | Class A Common Stock | |
| Petmed Express Inc | Sandra Y. Campos | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 146,772 | 638,987 (3%) | 0% | 0 | Common Stock | |
| Petmed Express Inc | Sandra Y. Campos | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 146,772 | 146,772 | - | - | Performance Share Units | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 15 Jan 2025 | 141,061 | 2,000,000 | - | 6.3 | 884,142 | Class A Common Stock |
| Townsquare Media Inc (Class A) | Bill Wilson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 137,817 | 2,447,397 (17%) | 0% | 0 | Class A Common Units | |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 129,395 | 325,607 | - | - | Restricted Stock Unit | |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | 15 Jan 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Chewy Inc (Class A) | Sumit Singh | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.70 per share. | 15 Jan 2025 | 114,130 | 529,809 (0%) | 0% | 37.7 | 4,302,244 | Class A Common Stock |
| Liberty Latin America Ltd (Class A) | Balan Nair | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 113,513 | 1,516,925 (3%) | 0% | - | Class C Common Shares | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | 15 Jan 2025 | 110,408 | 110,408 | - | 0 | Class A Common Stock | ||
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 110,408 | 1,072,537 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 110,408 | 2,047,687 | - | - | Class B Common Stock | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | 15 Jan 2025 | 110,408 | 1,937,279 | - | - | Class B Common Stock | ||
| Apyx Medical Corp | Shawn D. Roman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 100,000 | 100,000 | - | - | Stock Option (Option to Buy) | |
| Spyre Therapeutics Inc | Heidy King-Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 95,500 | 95,500 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc | Scott L. Burrows | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 95,500 | 95,500 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc | Sheldon Sloan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 95,500 | 95,500 | - | - | Stock Option (Right to Buy) | |
| Credo Tech Grp Holding Ltd | Lip-Bu Tan | Director | Sale of securities on an exchange or to another person at price $ 71.94 per share. | 15 Jan 2025 | 92,969 | 1,020,756 | - | 71.9 | 6,688,339 | Ordinary Shares |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | 15 Jan 2025 | 90,866 | 90,866 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | 15 Jan 2025 | 90,866 | 57,351,246 | - | - | Class B Common Stock | ||
| Sabra Healthcare REIT Inc | Talya Nevo-Hacohen | Executive VP, CIO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 90,044 | 322,007 (0%) | 0% | 0 | Common Stock | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 86,749 | 985,788 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 86,749 | 2,024,028 | - | - | Class B Common Stock | |
| Townsquare Media Inc (Class A) | Stuart Rosenstein | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 84,533 | 556,632 (3%) | 0% | 0 | Class A Common Units | |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Executive Chair of the Board, Ten Percent Owner | 15 Jan 2025 | 84,000 | 16,734,072 | - | - | Class B Common Stock | ||
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Executive Chair of the Board, Ten Percent Owner | 15 Jan 2025 | 84,000 | 84,000 | - | 0 | Class A Common Stock | ||
| Schlumberger | Olivier Le Peuch | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 83,031 | 83,031 | - | - | RSU (Restricted Stock Unit) | |
| Walt Disney | Hugh F. Johnston | SEVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 80,490 | 80,490 | - | - | Stock Option (Right-to-Buy) | |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 80,396 | 186,845 | - | 0 | Class A Common Stock | |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 80,396 | 0 | - | - | Restricted Stock Units | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.44 per share. | 15 Jan 2025 | 79,530 | 666,971 | - | 2.4 | 194,053 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 79,365 | 0 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 79,365 | 305,442 | - | 0 | Class A Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 77,049 | 160,133 (0%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 77,049 | 154,100 | - | - | Restricted Stock Units (2024) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.33 per share. | 15 Jan 2025 | 74,299 | 1,374,898 | - | 45.3 | 3,367,862 | Class A Common Stock |
| Keurig Dr Pepper | Robert J. Gamgort | Director, Executive Chairman | 15 Jan 2025 | 73,785 | 3,612,275 (0%) | 0% | 0 | Common Stock | ||
| Keurig Dr Pepper | Robert J. Gamgort | Director, Executive Chairman | 15 Jan 2025 | 73,785 | 0 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 73,448 | 240,841 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 73,448 | 252,159 | - | - | Restricted Stock Unit | |
| Townsquare Media Inc (Class A) | Erik Hellum | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 70,444 | 772,793 (5%) | 0% | 0 | Class A Common Units | |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 70,000 | 406,707 (0%) | 0% | 0 | Common Stock | |
| Walt Disney | Horacio E. Gutierrez | Sr EVP and Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 66,659 | 66,659 | - | - | Stock Option (Right-to-Buy) | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 66,186 | 66,186 | - | - | Restricted Stock Units (2023) | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 66,186 | 107,573 (0%) | 0% | - | Common Stock | |
| Townsquare Media Inc (Class A) | Stuart Rosenstein | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 66,152 | 472,930 (3%) | 0% | 0 | Class A Common Units | |
| Paychex | B. Thomas Golisano | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 143.73 per share. | 15 Jan 2025 | 66,075 | 36,965,344 (10%) | 0% | 143.7 | 9,496,960 | Common Stock |
| Fate Therapeutics Inc | Jerome Charles Bressi | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 65,000 | 335,203 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 63,782 | 340,755 (0%) | 0% | 0 | Common Stock | |
| Conduent Inc | A. Scott Letier | Director | Grant, award, or other acquisition of securities at price $ 4.06 per share. | 15 Jan 2025 | 62,624 | 591,256 (0%) | 0% | 4.1 | 254,253 | Common Stock |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Jan 2025 | 62,500 | 4,087,727 | - | 0.8 | 50,000 | Common Stock, par value $.001 |
| Charter (Class A) | Thomas M. Rutledge | Director Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.76 per share. | 15 Jan 2025 | 62,051 | 63,563 (0%) | 0% | 175.8 | 10,906,084 | Class A Common Stock |
| Charter (Class A) | Thomas M. Rutledge | Director Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 62,051 | 0 | - | - | Stock Options | |
| Neurocrine Biosciences Inc | Kyle W. Gano | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.99 per share. | 15 Jan 2025 | 60,188 | 195,580 (0%) | 0% | 33.0 | 1,985,602 | Common Stock |
| Neurocrine Biosciences Inc | Kyle W. Gano | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 141.50 per share. | 15 Jan 2025 | 60,188 | 135,392 (0%) | 0% | 141.5 | 8,516,656 | Common Stock |
| Neurocrine Biosciences Inc | Kyle W. Gano | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 60,188 | 0 | - | - | Non-Qualified Stock Option | |
| Nextdoor Holdings Inc (Class A) | Matthew S. Anderson | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.44 per share. | 15 Jan 2025 | 55,399 | 580,024 | - | 2.4 | 135,174 | Class A Common Stock |
| Townsquare Media Inc (Class A) | Erik Hellum | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 55,127 | 702,349 (4%) | 0% | 0 | Class A Common Units | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 54,794 | 54,794 (0%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 54,794 | 0 | - | - | Restricted Stock Units (2022) | |
| Maravai LifeSciences Holdings Inc (Class A) | Andrew Burch | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 54,412 | 369,183 | - | 4.6 | 248,119 | Class A Common Stock |
| Bone Biologics Corp | Jeffrey Frelick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 54,110 | 54,110 | - | - | Employee Stock Option | |
| Credo Tech Grp Holding Ltd | Lip-Bu Tan | Director | Sale of securities on an exchange or to another person at price $ 74.13 per share. | 15 Jan 2025 | 50,000 | 963,725 | - | 74.1 | 3,706,275 | Ordinary Shares |
| Apyx Medical Corp | Lawrence J. Waldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Charles D. Goodwin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Minnie V. Baylor-Henry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Wendy Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Schneider National Inc (Class B) | Kathleen M. Zimmermann | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jan 2025 | 49,064 | 551,612 (0%) | 0% | 0 | Class B Common Stock | |
| Schneider National Inc (Class B) | Paul J. Schneider | Ten Percent Owner | 15 Jan 2025 | 49,064 | 575,663 (0%) | 0% | 0 | Class B Common Stock | ||
| Schneider National Inc (Class B) | Therese A. Koller | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jan 2025 | 49,056 | 1,760,723 (1%) | 0% | 0 | Class B Common Stock | |
| Core & Main Inc (Class A) | Mark G. Whittenburg | General Counsel and Secretary | 15 Jan 2025 | 48,026 | 55,693 | - | 0 | Class A Common Stock | ||
| Core & Main Inc (Class A) | Mark G. Whittenburg | General Counsel and Secretary | 15 Jan 2025 | 48,026 | 7,667 | - | 55.1 | 2,647,659 | Class A Common Stock | |
| Core & Main Inc (Class A) | Mark G. Whittenburg | General Counsel and Secretary | 15 Jan 2025 | 48,026 | 302,812 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| Core & Main Inc (Class A) | Mark G. Whittenburg | General Counsel and Secretary | 15 Jan 2025 | 48,026 | 48,026 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| Core & Main Inc (Class A) | Mark G. Whittenburg | General Counsel and Secretary | 15 Jan 2025 | 48,026 | 0 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| Conduent Inc | Michael Montelongo | Director | Grant, award, or other acquisition of securities at price $ 4.06 per share. | 15 Jan 2025 | 46,799 | 271,279 (0%) | 0% | 4.1 | 190,004 | Common Stock |
| Conduent Inc | Kathy Higgins Victor | Director | 15 Jan 2025 | 46,799 | 260,001 (0%) | 0% | 4.1 | 190,004 | Common Stock | |
| Conduent Inc | Margarita Palau Hernandez | Director | Grant, award, or other acquisition of securities at price $ 4.06 per share. | 15 Jan 2025 | 46,799 | 310,313 (0%) | 0% | 4.1 | 190,004 | Common Stock |
| Ionis Pharma Inc | Elizabeth L. Hougen | EVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 46,500 | 108,556 | - | - | Restricted Stock Unit | |
| Maravai LifeSciences Holdings Inc (Class A) | Kevin Herde | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 46,344 | 290,256 | - | 4.6 | 211,329 | Class A Common Stock |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 45.28 per share. | 15 Jan 2025 | 45,789 | 0 | - | 45.3 | 2,073,253 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Rebecca Buzzeo | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 45,456 | 315,247 | - | 4.6 | 207,279 | Class A Common Stock |
| Charter (Class A) | Thomas M. Rutledge | Director Emeritus | Payment of exercise price or tax liability using portion of securities received from the company at price $ 348.00 per share. | 15 Jan 2025 | 45,169 | 18,394 (0%) | 0% | 348 | 15,718,812 | Class A Common Stock |
| Hexcel Corp | Nick L. Stanage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 45,163 | 447,026 (0%) | 0% | 0 | Common Stock | |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 45.27 per share. | 15 Jan 2025 | 45,077 | 45,789 | - | 45.3 | 2,040,636 | Class A Common Stock |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Executive Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 62.68 per share. | 15 Jan 2025 | 44,663 | 39,337 | - | 62.7 | 2,799,477 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 15 Jan 2025 | 44,593 | 1,825,848 | - | 45.1 | 2,011,242 | Class A Common Stock |
| BioXcel Therapeutics Inc | Rajiv Patni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 15 Jan 2025 | 43,000 | 559,925 (2%) | 0% | 2.2 | 95,890 | Common Stock |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 15 Jan 2025 | 42,717 | 1,957,283 | - | 6.9 | 294,918 | Class A Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 42,026 | 84,055 | - | - | Restricted Stock Units (2024) | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 42,026 | 483,810 (0%) | 0% | - | Common Stock | |
| Upstart Holdings Inc | Dave Girouard | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 41,667 | 1,085,077 | - | - | Employee Stock Option (Right to buy) | |
| Upstart Holdings Inc | Dave Girouard | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.83 per share. | 15 Jan 2025 | 41,667 | 98,805 | - | 0.8 | 34,584 | Common Stock |
| Liberty Latin America Ltd (Class A) | Balan Nair | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.57 per share. | 15 Jan 2025 | 41,191 | 1,475,734 (3%) | 0% | 6.6 | 270,625 | Class C Common Shares |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 40,590 | 427,184 (0%) | 0% | - | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 40,590 | 0 | - | - | Restricted Stock Units (2022) | |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.67 per share. | 15 Jan 2025 | 40,000 | 27,136 (0%) | 0% | 31.7 | 1,266,800 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 255.37 per share. | 15 Jan 2025 | 39,896 | 146,949 | - | 255.4 | 10,188,242 | Class A Common Stock |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 39,692 | 653,354 (0%) | 0% | - | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 39,692 | 79,385 | - | - | Restricted Stock Units (2024) | |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Executive Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 63.35 per share. | 15 Jan 2025 | 39,337 | 0 | - | 63.4 | 2,491,999 | Class A Common Stock |
| Chord Energy Corp - Ordinary Shares - New | Michael H. Lou | EVP, CSO, and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.70 per share. | 15 Jan 2025 | 37,014 | 85,429 | - | 126.7 | 4,689,674 | Common Stock |
| Verisk Analytics | Lee M. Shavel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 36,979 | 36,979 | - | - | Stock Option | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 36,101 | 454,355 (0%) | 0% | - | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 36,101 | 36,102 | - | - | Restricted Stock Units (2023) | |
| Upstart Holdings Inc | Dave Girouard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 62.52 per share. | 15 Jan 2025 | 36,092 | 62,713 | - | 62.5 | 2,256,504 | Common Stock |
| Apyx Medical Corp | Moshe Citronowicz | Sr. V.P. of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 36,000 | 36,000 | - | - | Stock Option (Option to Buy) | |
| Concrete Pumping Holdings Inc (Class A) | Bruce Young | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 35,793 | 1,720,849 (2%) | 0% | 0 | Common Stock | |
| PayPal | Diego Scotti | EVP, GM Consumer & Global Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 34,354 | 68,704 | - | - | Restricted Stock Units -1 | |
| PayPal | Diego Scotti | EVP, GM Consumer & Global Mkt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 34,354 | 34,354 (0%) | 0% | 0 | Common Stock | |
| Charter (Class A) | Christopher Winfrey L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 34,046 | 0 | - | - | Stock Options | |
| Charter (Class A) | Christopher Winfrey L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.76 per share. | 15 Jan 2025 | 34,046 | 91,827 (0%) | 0% | 175.8 | 5,983,925 | Class A Common Stock |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.63 per share. | 15 Jan 2025 | 33,445 | 207,396 (0%) | 0% | 32.6 | 1,091,444 | Common Stock |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 79,625 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | 15 Jan 2025 | 33,000 | 56,500 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 80,414 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Eric E. Swayze | EVP Research | 15 Jan 2025 | 33,000 | 79,728 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 86,135 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 15 Jan 2025 | 33,000 | 78,308 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Brian Birchler | EVP, Corp and Development Ops | 15 Jan 2025 | 33,000 | 77,373 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 75,521 | - | - | Restricted Stock Unit | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 32,687 | 65,377 | - | - | Restricted Stock Units (2024) | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 32,687 | 314,624 (0%) | 0% | - | Common Stock | |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.41 per share. | 15 Jan 2025 | 32,473 | 2,147,203 | - | 3.4 | 110,733 | Class A Common Stock |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.69 per share. | 15 Jan 2025 | 32,357 | 61,042 | - | 170.7 | 5,523,016 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Peter M. Leddy | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 32,042 | 343,739 | - | 4.6 | 146,112 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Kurt Oreshack | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 31,438 | 192,618 | - | 4.6 | 143,357 | Class A Common Stock |
| Ionis Pharma Inc | Elizabeth L. Hougen | EVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 31,000 | 86,635 | - | - | Performance Restricted Stock Units | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 30,440 | 0 | - | - | Restricted Stock Units (2022) | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 30,440 | 599,095 (0%) | 0% | - | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 30,084 | 622,482 (0%) | 0% | - | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 30,084 | 30,085 | - | - | Restricted Stock Units (2023) | |
| Alignment Healthcare Inc | Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 13.61 per share. | 15 Jan 2025 | 30,000 | 1,606,097 | - | 13.6 | 408,384 | Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 15 Jan 2025 | 30,000 | 2,203,787 | - | 3.5 | 105,000 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.44 per share. | 15 Jan 2025 | 29,930 | 275,512 | - | 2.4 | 73,029 | Class A Common Stock |
| Invesco Ltd | Douglas J. Sharp | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 29,188 | 139,047 (0%) | 0% | 0 | Common Shares | |
| Invesco Ltd | Douglas J. Sharp | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 29,188 | 87,566 | - | - | Restricted Stock Units | |
| Esquire Fin Holdings Inc | Andrew C. Sagliocca | Director, Vice Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 15 Jan 2025 | 29,000 | 277,081 (3%) | 0% | 12.5 | 362,500 | Common Stock |
| Esquire Fin Holdings Inc | Andrew C. Sagliocca | Director, Vice Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 29,000 | 29,250 | - | - | Stock Options | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 28,704 | 231,634 | - | 4.6 | 130,890 | Class A Common Stock |
| Entera Bio Ltd | Gerald M. Ostrov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,509 | 28,509 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,509 | 28,509 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,509 | 28,509 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Haya Taitel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,509 | 28,509 | - | - | Stock Option (right to buy) | |
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 28,509 | 131,624 (0%) | 0% | 21.8 | 621,496 | Common Stock |
| News Corp (Class A) | Lavanya Chandrashekar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,311 | 28,311 | - | - | Stock-Settled Restricted Stock Units | |
| Walt Disney | Hugh F. Johnston | SEVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,150 | 28,150 | - | - | Restricted Stock Unit | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 28,079 | 289,622 (0%) | 0% | - | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 28,079 | 28,080 | - | - | Restricted Stock Units (2023) | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,050 | 28,050 | - | - | Restricted Stock Unit | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 27,803 | 267,660 (0%) | 0% | - | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 27,803 | 0 | - | - | Restricted Stock Units (2022) | |
| Bone Biologics Corp | Deina H. Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 27,055 | 27,055 | - | - | Employee Stock Option | |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 15 Jan 2025 | 27,000 | 276,062 | - | 27.9 | 751,950 | Class A Common Stock |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 27,000 | 312,780 | - | - | Stock Option (Right to Buy) | |
| AMN Healthcare Services Inc | Brian Scott | CFO/COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 26,799 | 26,799 | - | - | Restricted Stock Units | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 26,586 | 0 | - | - | Restricted Stock Units (2022) | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 26,586 | 381,647 (0%) | 0% | - | Common Stock | |
| Alight Inc (Class A) | Deepika Duggirala | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 26,509 | 67,984 | - | 0 | Class A Common Stock | |
| Community Healthcare Trust Inc | David H. Dupuy | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 19.03 per share. | 15 Jan 2025 | 26,275 | 448,500 (2%) | 0% | 19.0 | 500,013 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.34 per share. | 15 Jan 2025 | 26,050 | 72,749 | - | 45.3 | 1,181,018 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.33 per share. | 15 Jan 2025 | 26,028 | 73,084 | - | 45.3 | 1,179,966 | Class A Common Stock |
| Community Healthcare Trust Inc | William G. Monroe | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 19.03 per share. | 15 Jan 2025 | 25,981 | 143,409 (0%) | 0% | 19.0 | 494,418 | Common Stock |
| Charter (Class A) | Christopher Winfrey L. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 348.00 per share. | 15 Jan 2025 | 25,254 | 66,573 (0%) | 0% | 348 | 8,788,392 | Class A Common Stock |
| Coursera Inc | Andrew Y. Ng | Director | Sale of securities on an exchange or to another person at price $ 8.67 per share. | 15 Jan 2025 | 25,000 | 7,246,671 | - | 8.7 | 216,660 | Common Stock |
| Zoom Video Comm Inc (Class A) | Jonathan C. Chadwick | Director | 15 Jan 2025 | 25,000 | 50,000 | - | - | Class B Common Stock | ||
| Zoom Video Comm Inc (Class A) | Jonathan C. Chadwick | Director | 15 Jan 2025 | 25,000 | 26,514 (0%) | 0% | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.32 per share. | 15 Jan 2025 | 24,907 | 73,815 | - | 45.3 | 1,128,723 | Class A Common Stock |
| Schlumberger | Khaled Mugharbel | EVP, Geographies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 24,826 | 24,826 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Stephane Biguet | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 24,826 | 24,826 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Abdellah Merad | EVP, Core Services & Equipment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 24,826 | 24,826 | - | - | RSU (Restricted Stock Unit) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.32 per share. | 15 Jan 2025 | 24,754 | 74,372 | - | 45.3 | 1,121,742 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.31 per share. | 15 Jan 2025 | 24,746 | 74,152 | - | 45.3 | 1,121,281 | Class A Common Stock |
| Walt Disney | Sonia L. Coleman | Sr. EVP and Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 24,607 | 24,607 | - | - | Stock Option (Right-to-Buy) | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.31 per share. | 15 Jan 2025 | 24,584 | 74,336 | - | 45.3 | 1,113,982 | Class A Common Stock |
| Schneider National Inc (Class B) | Mary P. Deprey | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jan 2025 | 24,528 | 570,674 (0%) | 0% | 0 | Class B Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 24,489 | 83,084 (0%) | 0% | 21.8 | 533,860 | Common Stock |
| Keurig Dr Pepper | Robert J. Gamgort | Director, Executive Chairman | 15 Jan 2025 | 24,420 | 3,587,855 (0%) | 0% | 31.0 | 756,287 | Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.31 per share. | 15 Jan 2025 | 24,285 | 74,597 | - | 45.3 | 1,100,254 | Class A Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 15 Jan 2025 | 24,111 | 2,179,676 | - | 3.4 | 81,977 | Class A Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP HR&Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 23,932 | 57,459 (0%) | 0% | - | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP HR&Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 23,932 | 47,865 | - | - | Restricted Stock Units (2024) | |
| Nextdoor Holdings Inc (Class A) | Matthew S. Anderson | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 23,919 | 95,677 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Matthew S. Anderson | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 23,919 | 491,397 | - | 0 | Class A Common Stock | |
| Ionis Pharma Inc | Elizabeth L. Hougen | EVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 23,887 | 84,669 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Elizabeth L. Hougen | EVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 23,887 | 116,755 (0%) | 0% | 0 | Common Stock | |
| Walt Disney | Horacio E. Gutierrez | Sr EVP and Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 23,313 | 23,313 | - | - | Restricted Stock Unit | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 15 Jan 2025 | 22,946 | 22,946 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 15 Jan 2025 | 22,946 | 193,502,146 | - | - | Class B Common Stock | ||
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 70.32 per share. | 15 Jan 2025 | 22,696 | 382,007 (0%) | 0% | 70.3 | 1,595,983 | Common Stock |
| Walt Disney | Kristina K. Schake | Sr. EVP and Chief Comm Officer | 15 Jan 2025 | 22,669 | 22,669 | - | - | Stock Option (Right-to-Buy) | ||
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP HR&Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 22,426 | 0 | - | - | Restricted Stock Units (2022) | |
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP HR&Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 22,426 | 22,426 (0%) | 0% | - | Common Stock | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 64,801 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | 15 Jan 2025 | 22,000 | 63,482 | - | - | Performance Restricted Stock Units | ||
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 64,801 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Eric E. Swayze | EVP Research | 15 Jan 2025 | 22,000 | 64,482 | - | - | Performance Restricted Stock Units | ||
| Ionis Pharma Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 51,290 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 15 Jan 2025 | 22,000 | 65,437 | - | - | Performance Restricted Stock Units | ||
| Ionis Pharma Inc | Brian Birchler | EVP, Corp and Development Ops | 15 Jan 2025 | 22,000 | 53,338 | - | - | Performance Restricted Stock Units | ||
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 22,000 | - | - | Performance Restricted Stock Units | |
| Principal Financial Group | Deanna Strable-Soethout D. | President and CEO | Grant, award, or other acquisition of securities at price $ 51.33 per share. | 15 Jan 2025 | 21,780 | 134,136 (0%) | 0% | 51.3 | 1,117,967 | Common Stock |
| Principal Financial Group | Deanna Strable-Soethout D. | President and CEO | Sale or transfer of securities back to the company at price $ 80.50 per share. | 15 Jan 2025 | 21,780 | 112,356 (0%) | 0% | 80.5 | 1,753,290 | Common Stock |
| News Corp (Class A) | Marygrace DeGrazio | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 21,778 | 21,778 | - | - | Stock-Settled Restricted Stock Units | |
| Candel Therapeutics Inc | Paul Peter Tak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 21,704 | 251,912 | - | 7.2 | 156,811 | Common Stock |
| Schlumberger | Dianne B. Ralston | Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 21,471 | 21,471 | - | - | RSU (Restricted Stock Unit) | |
| Charter (Class A) | Jamal H. Haughton | EVP/Gen Counsel/Corp Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 21,264 | 21,264 | - | - | Stock Options | |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 20,683 | 2,473,610 (0%) | 0% | - | Common Stock | |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Sale or transfer of securities back to the company at price $ 47.10 per share. | 15 Jan 2025 | 20,683 | 2,452,927 (0%) | 0% | 47.1 | 974,169 | Common Stock |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 20,683 | 20,683 | - | - | 2024 Cash Settled Restricted Stock Units | |
| Alight Inc (Class A) | Allison Bassiouni | Chief Delivery Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,618 | 65,788 | - | 0 | Class A Common Stock | |
| Alight Inc (Class A) | Robert Sturrus W. | Chief Client Officer | 15 Jan 2025 | 20,618 | 57,392 | - | 0 | Class A Common Stock | ||
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP HR&Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 20,558 | 38,050 (0%) | 0% | - | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP HR&Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 20,558 | 20,559 | - | - | Restricted Stock Units (2023) | |
| AMN Healthcare Services Inc | Mark Christopher Hagan | Chief Information and Digital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,099 | 20,099 | - | - | Restricted Stock Units | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.95 per share. | 15 Jan 2025 | 20,071 | 49,546 | - | 46.0 | 922,321 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.96 per share. | 15 Jan 2025 | 20,045 | 50,023 | - | 46.0 | 921,264 | Class A Common Stock |
| CalciMedica Inc | Alan Glicklich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,000 | 20,000 | - | - | Director Stock Option (Right to Buy) | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.65 per share. | 15 Jan 2025 | 20,000 | 629,938 (0%) | 0% | 51.7 | 1,033,074 | Common Stock |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | 15 Jan 2025 | 20,000 | 2,021,471 | - | - | Class B Common Stock | ||
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | 15 Jan 2025 | 20,000 | 67,136 (0%) | 0% | 0 | Class A Common Stock | ||
| Arhaus Inc (Class A) | Kathy E. Veltri | Chief Retail Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Arhaus Inc (Class A) | Jennifer Porter | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Arhaus Inc (Class A) | Lisa Chi | Chief Merchandising Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Coinbase Global Inc (Class A) | Alesia J. Haas | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 15 Jan 2025 | 20,000 | 124,470 | - | 300 | 6,000,000 | Class A Common Stock |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,000 | 20,000 | - | - | Restricted Stock Unit | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.96 per share. | 15 Jan 2025 | 19,953 | 49,853 | - | 46.0 | 916,958 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.96 per share. | 15 Jan 2025 | 19,812 | 50,216 | - | 46.0 | 910,518 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 19,707 | 98,534 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 19,707 | 234,114 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.96 per share. | 15 Jan 2025 | 19,703 | 50,087 | - | 46.0 | 905,570 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.94 per share. | 15 Jan 2025 | 19,697 | 50,034 | - | 45.9 | 904,947 | Class A Common Stock |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 19,690 | 68,563 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 19,690 | 60,724 | - | - | Restricted Stock Unit | |
| Equitable Holdings Inc | Nicholas B. Lane | See Remarks | Sale of securities on an exchange or to another person at price $ 51.64 per share. | 15 Jan 2025 | 19,604 | 127,025 (0%) | 0% | 51.6 | 1,012,429 | Common Stock |
| Genpact Ltd | Piyush Mehta | Senior Vice President and CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.34 per share. | 15 Jan 2025 | 19,511 | 143,671 (0%) | 0% | 43.3 | 845,607 | Common Shares |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.95 per share. | 15 Jan 2025 | 19,461 | 50,435 | - | 45.9 | 894,229 | Class A Common Stock |
| Ionis Pharma Inc | Eric E. Swayze | EVP Research | 15 Jan 2025 | 19,111 | 52,824 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | Eric E. Swayze | EVP Research | 15 Jan 2025 | 19,111 | 60,617 | - | - | Restricted Stock Unit | ||
| Q32 Bio Inc | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 19,008 | 19,008 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 19,008 | 19,008 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Isaac Manke | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 19,008 | 0 | - | - | Stock Option (Right to Buy) | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 18,901 | 60,724 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 18,901 | 103,735 (0%) | 0% | 0 | Common Stock | |
| Opendoor Tech Inc | Sydney Schaub | Chief Legal Officer | 15 Jan 2025 | 18,804 | 1,171,590 | - | 1.5 | 28,642 | Common Stock | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 18,750 | 75,000 | - | - | Stock Option (right to buy) | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.76 per share. | 15 Jan 2025 | 18,750 | 411,339 (0%) | 0% | 22.8 | 426,750 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 18,700 | 18,700 | - | - | Performance Restricted Stock Units | |
| Q32 Bio Inc | Grayzel S. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 18,595 | 18,595 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | David S. Grayzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 18,595 | 18,595 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Grayzel S. David | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 18,595 | 0 | - | - | Stock Option (Right to Buy) | |
| Community Healthcare Trust Inc | Timothy L. Meyer | EVP - Asset Management | Grant, award, or other acquisition of securities at price $ 19.03 per share. | 15 Jan 2025 | 18,380 | 202,825 (0%) | 0% | 19.0 | 349,771 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | 15 Jan 2025 | 18,011 | 97,618 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | 15 Jan 2025 | 18,011 | 38,489 | - | - | Restricted Stock Unit | ||
| Esquire Fin Holdings Inc | Ari P. Kornhaber | EVP and Head of Corp Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 15 Jan 2025 | 18,000 | 121,828 (1%) | 0% | 12.5 | 225,000 | Common Stock |
| Esquire Fin Holdings Inc | Ari P. Kornhaber | EVP and Head of Corp Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 18,000 | 11,125 | - | - | Stock Options | |
| Guardant Health Inc | Terilyn Juarez Monroe | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 17,378 | 34,758 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Terilyn Juarez Monroe | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 17,378 | 18,348 (0%) | 0% | 0 | Common Stock | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.20 per share. | 15 Jan 2025 | 17,378 | 319,859 | - | 2.2 | 38,232 | Common Stock |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 15 Jan 2025 | 17,372 | 65,031 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 15 Jan 2025 | 17,372 | 60,936 | - | - | Restricted Stock Unit | ||
| PayPal | Diego Scotti | EVP, GM Consumer & Global Mkt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.18 per share. | 15 Jan 2025 | 17,365 | 16,989 (0%) | 0% | 87.2 | 1,513,881 | Common Stock |
| Schlumberger | Gavin Rennick | President New Energy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 16,774 | 16,774 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Demosthenis Pafitis | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 16,774 | 16,774 | - | - | RSU (Restricted Stock Unit) | |
| AT&T | Edward Oliver Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 16,492 | 32,984 | - | - | Restricted Stock Units (2024) | |
| AT&T | Edward Oliver Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 16,492 | 216,858 (0%) | 0% | - | Common Stock | |
| System1 Inc (Class A) | Brian Coppola | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 15 Jan 2025 | 16,205 | 286,930 | - | 0.6 | 10,047 | Class A Common Stock |
| Orion Office REIT Inc | Paul H. McDowell | Director, See Remarks. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 15,989 | 322,070 | - | 0 | Common Stock | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 169.96 per share. | 15 Jan 2025 | 15,909 | 93,399 | - | 170.0 | 2,703,894 | Class A Common Stock |
| System1 Inc (Class A) | Daniel J. Weinrot | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 15 Jan 2025 | 15,839 | 193,309 | - | 0.6 | 9,820 | Class A Common Stock |
| Community Healthcare Trust Inc | Leigh Ann Stach | Executive Vice President & CAO | Grant, award, or other acquisition of securities at price $ 19.03 per share. | 15 Jan 2025 | 15,699 | 419,141 (1%) | 0% | 19.0 | 298,752 | Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 15,550 | 468,260 (0%) | 0% | 21.8 | 338,990 | Common Stock |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,367 | 0 | - | - | Restricted Stock Units (2022) | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,367 | 359,497 (0%) | 0% | - | Common Stock | |
| Concrete Pumping Holdings Inc (Class A) | Iain Humphries | Director, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 15,330 | 382,822 (0%) | 0% | 0 | Common Stock | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,292 | 400,389 (0%) | 0% | - | Common Stock | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,292 | 30,588 | - | - | Restricted Stock Units (2024) | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,121 | 30,244 | - | - | Restricted Stock Units (2024) | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,121 | 379,812 (0%) | 0% | - | Common Stock | |
| Atea Pharma Inc | Franklin M. Berger | Director | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 15 Jan 2025 | 15,000 | 466,897 | - | 3.2 | 47,885 | Common Stock |
| Esquire Fin Holdings Inc | Eric S. Bader | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 15,000 | 14,125 | - | - | Stock Options | |
| Esquire Fin Holdings Inc | Eric S. Bader | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 15 Jan 2025 | 15,000 | 130,548 (1%) | 0% | 12.5 | 187,500 | Common Stock |
| VYNE Therapeutics Inc | Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 15 Jan 2025 | 15,000 | 51,472 (0%) | 0% | 2.9 | 43,800 | Common Stock |
| Arhaus Inc (Class A) | Venkatachalam Nachiappan | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Chatham Lodging Trust | Robert Perlmutter | Director | 15 Jan 2025 | 14,772 | 108,662 (0%) | 0% | 9.1 | 135,016 | Common Shares | |
| AT&T | Edward Oliver Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,757 | 195,255 (0%) | 0% | - | Common Stock | |
| AT&T | Edward Oliver Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,757 | 0 | - | - | Restricted Stock Units (2022) | |
| GCM Grosvenor Inc (Class A) | Pamela L. Bentley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 14,708 | 14,708 | - | - | Restricted Stock Units | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 14,687 | 638,667 (0%) | 0% | 21.8 | 320,177 | Common Stock |
| Medalist Diversified REIT Inc | Frank Kavanaugh | Director, CHAIRMAN, CEO & PRESIDENT, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 14,547 | 402,591 | - | - | Operating Partnership Units | |
| Granite Point Mortgage Trust Inc | Patrick G. Halter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 14,362 | 14,362 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Lazar Nikolic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 14,362 | 14,362 | - | - | Restricted Stock Units | |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 14,322 | 96,790 | - | 7.2 | 103,476 | Common Stock |
| Ionis Pharma Inc | Brian Birchler | EVP, Corp and Development Ops | 15 Jan 2025 | 14,283 | 60,451 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | Brian Birchler | EVP, Corp and Development Ops | 15 Jan 2025 | 14,283 | 63,090 | - | - | Restricted Stock Unit | ||
| Walt Disney | Brent A. Woodford | EVP, Control, Fin Plan & Tax | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 14,193 | 14,193 | - | - | Stock Option (Right-to-Buy) | |
| AT&T | Edward Oliver Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,167 | 204,631 (0%) | 0% | - | Common Stock | |
| AT&T | Edward Oliver Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,167 | 14,167 | - | - | Restricted Stock Units (2023) | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,066 | 28,134 | - | - | Restricted Stock Units (2024) | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,066 | 229,012 (0%) | 0% | - | Common Stock | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | 15 Jan 2025 | 14,000 | 628,394 | - | 0 | Class A Common Stock | ||
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | 15 Jan 2025 | 14,000 | 1,326,944 | - | - | Class B Common Stock | ||
| Invesco Ltd | Douglas J. Sharp | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.05 per share. | 15 Jan 2025 | 13,719 | 125,328 (0%) | 0% | 17.1 | 233,909 | Common Shares |
| System1 Inc (Class A) | Tridivesh Kidambi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 15 Jan 2025 | 13,557 | 724,290 | - | 0.6 | 8,405 | Class A Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 13,534 | 110,673 | - | 7.2 | 97,783 | Common Stock |
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 13,407 | 41,387 (0%) | 0% | 21.8 | 292,273 | Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 13,137 | 387,988 (0%) | 0% | - | Common Stock | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 13,137 | 13,137 | - | - | Restricted Stock Units (2023) | |
| CarMax | Jill A. Livesay | VP, Controller & PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 13,009 | 0 | - | - | Stock Options (Right to Buy) | |
| CarMax | Jill A. Livesay | VP, Controller & PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.04 per share. | 15 Jan 2025 | 13,009 | 22,457 (0%) | 0% | 63.0 | 820,087 | Common Stock |
| CarMax | Jill A. Livesay | VP, Controller & PAO | Sale of securities on an exchange or to another person at price $ 81.00 per share. | 15 Jan 2025 | 13,009 | 9,448 (0%) | 0% | 81 | 1,053,729 | Common Stock |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,990 | 12,989 | - | - | Restricted Stock Units (2023) | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,990 | 368,262 (0%) | 0% | - | Common Stock | |
| Republic Bancorp Inc KY | Logan M. Pichel | Director, PRESIDENT & CEO, REPUBLIC BANK | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,978 | 12,978 | - | - | Employee Stock Option (right to buy) | |
| Q32 Bio Inc | Isaac Manke | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 12,767 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Manke Isaac | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | S. David Grayzel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 12,767 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Grayzel David S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) | |
| OppFi Inc (Class A) | Todd G. Schwartz | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 12,751 | 63,509,410 | - | 0 | Class V Common Stock | |
| Protagonist Therapeutics Inc | Dinesh V. Patel | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Jan 2025 | 12,636 | 545,619 (2%) | 0% | 0 | Common Stock | |
| Build A Bear Workshop Inc | J. Christopher Hurt | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 15 Jan 2025 | 12,635 | 49,386 (0%) | 0% | 39.5 | 499,441 | Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 12,571 | 441,784 (0%) | 0% | 21.8 | 274,048 | Common Stock |
| Zoom Video Comm Inc (Class A) | Jonathan C. Chadwick | Director | Sale of securities on an exchange or to another person at price $ 80.10 per share. | 15 Jan 2025 | 12,511 | 14,003 (0%) | 0% | 80.1 | 1,002,095 | Class A Common Stock |
| Anavex Life Sciences Corp | Sandra Boenisch | PFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Accel Entertainment Inc (Class A1) | David W. Ruttenberg | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 15 Jan 2025 | 12,500 | 348,135 (19%) | 0% | 10.6 | 132,591 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | David W. Ruttenberg | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 15 Jan 2025 | 12,500 | 488,026 (27%) | 0% | 10.6 | 132,588 | Class A-1 Common Stock |
| Zoom Video Comm Inc (Class A) | Jonathan C. Chadwick | Director | Sale of securities on an exchange or to another person at price $ 80.56 per share. | 15 Jan 2025 | 12,489 | 1,514 (0%) | 0% | 80.6 | 1,006,100 | Class A Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,295 | 63,226 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,295 | 20,204 (0%) | 0% | 0 | Common Stock | |
| AMD | Ava M. Hahn | SVP, GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,095 | 15,143 (0%) | 0% | 0 | Common Stock | |
| AMD | Ava M. Hahn | SVP, GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,095 | 18,142 | - | - | RSU Award | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.80 per share. | 15 Jan 2025 | 12,095 | 302,529 (0%) | 0% | 21.8 | 263,671 | Common Stock |
| Lifeway Foods Inc | Ludmila Smolyansky | Member of 10% owner group | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 15 Jan 2025 | 12,034 | 965,823 (6%) | 0% | 22.6 | 271,367 | Common Stock, no par value |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 174.89 per share. | 15 Jan 2025 | 11,852 | 23,890 | - | 174.9 | 2,072,796 | Class A Common Stock |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 11,804 | 0 | - | - | Restricted Stock Units (2022) | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 11,804 | 211,162 (0%) | 0% | - | Common Stock | |
| Chord Energy Corp - Ordinary Shares - New | Richard N. Robuck | EVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.70 per share. | 15 Jan 2025 | 11,765 | 19,263 | - | 126.7 | 1,490,626 | Common Stock |
| Chatham Lodging Trust | David J. Grissen | Director | Grant, award, or other acquisition of securities at price $ 9.14 per share. | 15 Jan 2025 | 11,763 | 31,472 (0%) | 0% | 9.1 | 107,514 | Common Shares |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 171.68 per share. | 15 Jan 2025 | 11,627 | 49,415 | - | 171.7 | 1,996,123 | Class A Common Stock |
| Walt Disney | Brent A. Woodford | EVP, Control, Fin Plan & Tax | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 11,582 | 11,582 | - | - | Restricted Stock Unit | |
| 8X8 Inc | Suzy Seandel | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 15 Jan 2025 | 11,376 | 305,607 (0%) | 0% | 2.7 | 30,943 | Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.84 per share. | 15 Jan 2025 | 11,339 | 1,363,559 | - | 45.8 | 519,765 | Class A Common Stock |
| System1 Inc (Class A) | Beth Sestanovich | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 15 Jan 2025 | 11,301 | 212,036 | - | 0.6 | 7,007 | Class A Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 11,266 | 446,400 | - | - | Employee Stock Option (right to buy) | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.18 per share. | 15 Jan 2025 | 11,266 | 659,938 (0%) | 0% | 23.2 | 261,146 | Common Stock |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 175.85 per share. | 15 Jan 2025 | 11,068 | 12,822 | - | 175.9 | 1,946,308 | Class A Common Stock |
| Alight Inc (Class A) | Siobhan Nolan Mangini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,954 | 28,789 | - | 0 | Class A Common Stock | |
| Orion Office REIT Inc | Christopher H. Day | See Remarks. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,938 | 189,863 | - | 0 | Common Stock | |
| Verisk Analytics | Elizabeth D. Mann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,758 | 10,758 | - | - | Stock Option | |
| AMN Healthcare Services Inc | Whitney M. Laughlin | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,719 | 10,719 | - | - | Restricted Stock Units | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 10,692 | 79,319 (0%) | 0% | 72.5 | 774,742 | Common Stock |
| Harmony Biosciences Holdings Inc | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.44 per share. | 15 Jan 2025 | 10,507 | 10,507 | - | 33.4 | 351,354 | Common Stock |
| Harmony Biosciences Holdings Inc | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 15 Jan 2025 | 10,507 | 0 | - | 37.0 | 388,841 | Common Stock |
| Harmony Biosciences Holdings Inc | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 10,507 | 36,213 | - | - | Stock Option | |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 10,428 | 79,320 | - | 7.2 | 75,342 | Common Stock |
| Synopsys | Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 10,322 | 8,847 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Richard S. Mahoney | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 319.20 per share. | 15 Jan 2025 | 10,322 | 18,125 (0%) | 0% | 319.2 | 3,294,782 | Common Stock |
| Synopsys | Richard S. Mahoney | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 505.99 per share. | 15 Jan 2025 | 10,322 | 7,803 (0%) | 0% | 506.0 | 5,222,796 | Common Stock |
| Concrete Pumping Holdings Inc (Class A) | Iain Humphries | Director, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,226 | 393,048 (0%) | 0% | 0 | Common Stock | |
| Schlumberger | Carmen Rando Bejar | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,064 | 10,064 | - | - | RSU (Restricted Stock Unit) | |
| Schlumberger | Rakesh Jaggi | Pres Digital & Integration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,064 | 10,064 | - | - | RSU (Restricted Stock Unit) | |
| Sabra Healthcare REIT Inc | Jessica Flores | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,048 | 76,203 (0%) | 0% | 0 | Common Stock | |
| Atea Pharma Inc | Franklin M. Berger | Director | Purchase of securities on an exchange or from another person at price $ 3.36 per share. | 15 Jan 2025 | 10,000 | 476,897 | - | 3.4 | 33,614 | Common Stock |
| Heritage Global Inc | David Ludwig | Director, President of subsidiary | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 15 Jan 2025 | 10,000 | 967,479 | - | 2.1 | 20,700 | Common Stock |
| Yelp Inc | David A. Schwarzbach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.51 per share. | 15 Jan 2025 | 10,000 | 191,988 (0%) | 0% | 39.5 | 395,067 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.